{"schema_version":"1","generated_at":"2026-11-05T13:12:07.904Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jodi-muscal","json_url":"https://www.findmykol.com/kol/jodi-muscal/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jodi-muscal","name":"Jodi Muscal","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Pfizer","institution_url":"https://www.findmykol.com/institution/pfizer","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1275731762","orcid":"0000-0002-3906-8534","openalex":"A5010485986"},"summary":"Jodi Muscal is an Oncology physician affiliated with Pfizer. OpenAlex indexes 41 publications with 728 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":41,"cited_by_count":728,"h_index":15,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02354547","title":"A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors","phase":"PHASE1","status":"SUSPENDED","role":"Overall official","sponsor":"SynerGene Therapeutics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT02354547","trial_url":"https://www.findmykol.com/trial/NCT02354547"},{"nct":"NCT00994500","title":"Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT00994500","trial_url":"https://www.findmykol.com/trial/NCT00994500"}],"source":"trials"},"publications":{"total":41,"shown":5,"withheld":36,"matched_by":"OpenAlex author record","recent":[{"title":"Phase I/II Study of Palbociclib + Chemotherapy in Recurrent/Refractory Pediatric Solid Tumors in a Randomly Assigned Cohort With Ewing Sarcoma","year":2026,"journal":"JCO oncology advances.","source_url":"https://doi.org/10.1200/oa-26-00050","status":"verified"},{"title":"Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration","year":2025,"journal":"European Journal of Cancer","source_url":"https://doi.org/10.1016/j.ejca.2025.115629","status":"verified"},{"title":"Evaluation of palbociclib in combination with topotecan and cyclophosphamide in pediatric patients with recurrent or refractory neuroblastoma.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps10069","status":"verified"},{"title":"Phase 2 study to evaluate palbociclib in combination with irinotecan and temozolomide in pediatric patients with recurrent or refractory Ewing sarcoma.","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps11583","status":"verified"},{"title":"Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors","year":2021,"journal":"Cancer Medicine","source_url":"https://doi.org/10.1002/cam4.3658","status":"verified"}],"source":"works"},"contact":{"address_1":"6701 FANNIN ST","city":"Houston","state":"TX","zip":"770302316","phone":"832-822-4890","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1275731762","source":"identity"},"similar":[{"name":"Johanna Bendell","slug":"johanna-bendell","institution":"Pfizer","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/johanna-bendell","json_url":"https://www.findmykol.com/kol/johanna-bendell/profile.json"},{"name":"Yoshiko Umeyama","slug":"yoshiko-umeyama","institution":"Pfizer","url":"https://www.findmykol.com/kol/yoshiko-umeyama","json_url":"https://www.findmykol.com/kol/yoshiko-umeyama/profile.json"},{"name":"Lídia Sànchez-Riera","slug":"lidia-sanchez-riera","institution":"Pfizer","url":"https://www.findmykol.com/kol/lidia-sanchez-riera","json_url":"https://www.findmykol.com/kol/lidia-sanchez-riera/profile.json"},{"name":"Philip Dormitzer","slug":"philip-dormitzer","institution":"Pfizer","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/philip-dormitzer","json_url":"https://www.findmykol.com/kol/philip-dormitzer/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":36}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2010-08-12","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}